Life sciences group OptiBiotix Health plc (LON:OPTI) has told investors that its health supplements were a massive hit when they were launched at the Vitafoods Europe tradeshow in Geneva last week.
Opti said it has already received draft contracts from several companies at the fair which are interested in selling its products; including its CholBiome, CardioBiome and SlimBiome supplements.
The products were exhibited in the New Products zone, as well as at the stands of AIM-quoted Opti’s European manufacturing and formulation partners, Sacco and Nutrilinea.
Interest expected to turn into revenues
“We are extremely pleased with the very high level of interest from both national and multinational companies interested in selling our products,” said chief executive Stephen O’Hara.
“This has already resulted in some companies sending through draft contracts.
“The company anticipates that this interest will start to generate revenues from both ingredient supply, and as a component in high value white label and branded formulations and presentations, across multiples territories.”
CholBiome and CardioBiome both contain OptiBiotix’s LPLDL strain which has been shown to reduce cholesterol levels, blood pressure and cardiovascular risk.
SlimBiome on the other hand is its weight management technology. It increases the microbial diversity and number of healthy bacteria in your gut which improves a dieter’s chances of losing weight and then sustaining that weight loss.
Opti starting to commercialise its technology
In recent months the company has been working hard to commercialise its products and although it’s only at the start of this process, it’s already made decent progress.
Only last week OptiBiotix inked a non-exclusive agreement with Italy-based supplements provider Nutrilinea to produce, promote, market and commercialise health-focused products containing CholBiome and CardioBiome.
Back in March, the company also signed an exclusive deal with raw ingredients provider Sacco to manufacture and supply the LPLDL strain.
SlimBiome is a little bit further down the line; it has been used as a key ingredient in the GoFigure range of dieting products for some time.
The supplements are made by The Health Weight Loss Company – in which Opti has a 64% stake – and demand has been so strong that it recently had to pump in more money to help THWC keep up with demand.
OptiBiotix is also working on a calorie-free, naturally sweet fibre which it hopes will be a healthier alternative to sugar. UNlike a lot of similar products on the market, such as stevia, the company said there will be no taste trade-off.